Neostigmine News and Research

RSS

Newer drug associated with significantly reduced rates of pulmonary complications

The tragic COVID-19 pandemic is creating new awareness regarding the importance of breathing problems, pneumonia and ventilators.

8 Apr 2020

Researchers take another promising step toward developing universal antidote for snakebite

A team of researchers, led by Dr. Matthew Lewin of the California Academy of Sciences and Dr. Stephen P. Samuel of Trinity College Dublin, Ireland has taken another promising step toward developing a universal antidote for snakebite.

29 May 2014

Neuromuscular blockade (NMB) reversal

General anesthesia is made up of three components: hypnotic medicines, to induce sleep; analgesics, or medicines to inhibit pain; and NMB agents that induce muscle relaxation. Anesthesiology professionals use NMB to relax a patient’s muscles and prevent involuntary movement that could impact surgery.

24 Jan 2013

Intermediate-acting neuromuscular block use ‘needs revisiting’

The use of intermediate-acting neuromuscular blocking agents during general anesthesia may increase the risk for clinically meaningful respiratory complications, researchers report in the BMJ.

17 Oct 2012

ASA survey shows more than 90% of respondents experience anesthesia drug shortage

The American Society of Anesthesiologists today announced the findings from its nationwide Drug Shortages Survey. Results showed that more than 90 percent of anesthesiologist respondents are currently experiencing a shortage of at least one anesthetic.

10 May 2011

Adding a drug called neostigmine to epidural analgesia reduces dose needed during labor

Adding a drug called neostigmine to epidural analgesia during labor can reduce the amount of anesthetic drug required, while avoiding potential complications caused by morphine-like "opioid" drugs, according to a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

27 Jul 2009